Integrating Transcriptomics and Metabolomics for Clinical Disease Detection: A Critical Review of Emerging Diagnostic Methodologies.
It is reported that no biomarker derived from integrated transcriptomic-metabolomic analysis has undergone analytical validation, entered regulatory qualification, or reached clinical implementation, and that where diagnostic performance is reported it belongs to a single-platform model rather than to the integrated si...